Table 5.
BMQ (M) | BIPQ (X) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total (c) | X → M (a) | M → Y (b) | X → Y (c’) | Indirect effect (a*b) | ||||||||||
c | SE | P | a | SE | P | b | SE | P | c’ | SE | P | a*b | 95% Cl | |
Specific Necessity | −0.086 | 0.021 | 0.000 | 0.002 | 0.004 | 0.5605 | −0.365 | 0.331 | 0.271 | −0.085 | 0.021 | 0.0001 | −0.001 | −0.005 to 0.003 |
Specific Concern | 0.019 | 0.004 | 0.0000 | −1.418 | 0.316 | 0.000 | −0.058 | 0.021 | 0.0057 | −0.027 | −0.044 to −0.014 | |||
General Overuse | 0.014 | 0.004 | 0.0007 | −1.957 | 0.281 | 0.000 | −0.059 | 0.020 | 0.0026 | −0.026 | −0.044 to −0.011 | |||
General Harm | 0.009 | 0.004 | 0.0174 | −1.841 | 0.291 | 0.000 | −0.069 | 0.020 | 0.0005 | −0.017 | −0.034 to −0.003 |
Notes: All analyses were performed separately according to each medication belief mediator. Data adjusted by age, sex, The National Institute of Health Stroke Scale (NIHSS), education, occupation, duration of disease, and payment methods.
Abbreviations: BMQ, Beliefs about Medicines Questionnaire; BIPQ, Brief Illness Perception Questionnaire; M, Medication belief mediators; X, The perception of illness; Y, Medication adherence.